HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Petersen, C. E. Articles by Bhagavan, N. V. Search for Related Content PubMed PubMed Citation Articles by Petersen, C. E. Articles by Bhagavan, N. V. Social Bookmarking                      What's this?

Volume 271, Number 32, Issue of August 9, 1996 pp. 19110-19117
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

---

Mutations in a Specific Human Serum Albumin Thyroxine Binding Site Define the Structural Basis of Familial Dysalbuminemic Hyperthyroxinemia

(Received for publication, April 1, 1996, and in revised form, May 16, 1996)

From the Department of Biochemistry and Biophysics, University of Hawaii, Honolulu, Hawaii 96822

The familial dysalbuminemic hyperthyroxinemia (FDH) phenotype results from a natural human serum albumin (HSA) mutant with histidine instead of arginine at amino acid position 218. This mutation results in an enhanced affinity for thyroxine. Site-directed mutagenesis and a yeast protein expression system were used to synthesize wild type HSA and FDH HSA as well as several other HSA mutants. Studies on the binding of thyroxine to these HSA species using equilibrium dialysis and quenching of tryptophan 214 fluorescence suggest that the FDH mutation affects a single thyroxine binding site located in the 2A subdomain of HSA. Site-directed mutagenesis of HSA and thyroxine analogs were used to obtain information about the mechanism of thyroxine binding to both wild type and FDH HSA. These studies suggest that the guanidino group of arginine at amino acid position 218 in wild type HSA is involved in an unfavorable binding interaction with the amino group of thyroxine, whereas histidine at amino acid position 218 in FDH HSA is involved in a favorable binding interaction with thyroxine. Neither arginine at amino acid position 222 nor tryptophan at amino acid position 214 appears to favorably influence the binding of thyroxine to wild type HSA.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				I. Petitpas, C. E. Petersen, C.-E. Ha, A. A. Bhattacharya, P. A. Zunszain, J. Ghuman, N. V. Bhagavan, and S. Curry Structural basis of albumin-thyroxine interactions and familial dysalbuminemic hyperthyroxinemia PNAS, May 27, 2003; 100(11): 6440 - 6445. [Abstract] [Full Text] [PDF]

				S. Pannain, M. Feldman, U. Eiholzer, R. E. Weiss, N. H. Scherberg, and S. Refetoff Familial Dysalbuminemic Hyperthyroxinemia in a Swiss Family Caused by a Mutant Albumin (R218P) Shows an Apparent Discrepancy between Serum Concentration and Affinity for Thyroxine J. Clin. Endocrinol. Metab., August 1, 2000; 85(8): 2786 - 2792. [Abstract] [Full Text]

				C. E. Petersen, C.-E. Ha, K. Harohalli, D. S. Park, J. B. Feix, O. Isozaki, and N. V. Bhagavan Structural Investigations of a New Familial Dysalbuminemic Hyperthyroxinemia Genotype Clin. Chem., August 1, 1999; 45(8): 1248 - 1254. [Abstract] [Full Text] [PDF]

				T. Sunthornthepvarakul, S. Likitmaskul, S. Ngowngarmratana, K. Angsusingha, S. Kitvitayasak, N. H. Scherberg, and S. Refetoff Familial Dysalbuminemic Hypertriiodothyroninemia: A New, Dominantly Inherited Albumin Defect J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1448 - 1454. [Abstract] [Full Text]

				N. Wada, H. Chiba, C. Shimizu, H. Kijima, M. Kubo, and T. Koike A Novel Missense Mutation in Codon 218 of the Albumin Gene in a Distinct Phenotype of Familial Dysalbuminemic Hyperthyroxinemia in a Japanese Kindred J. Clin. Endocrinol. Metab., October 1, 1997; 82(10): 3246 - 3250. [Abstract] [Full Text] [PDF]

				C. E. Petersen, C.-E. Ha, K. Harohalli, J. B. Feix, and N. V. Bhagavan A Dynamic Model for Bilirubin Binding to Human Serum Albumin J. Biol. Chem., July 7, 2000; 275(28): 20985 - 20995. [Abstract] [Full Text] [PDF]

				R. G. Eckenhoff, C. E. Petersen, C.-E. Ha, and N. V. Bhagavan Inhaled Anesthetic Binding Sites in Human Serum Albumin J. Biol. Chem., September 22, 2000; 275(39): 30439 - 30444. [Abstract] [Full Text] [PDF]